According to a recent LinkedIn post from Resilience Care, the company is engaging with oncology leaders at the Community Oncology Alliance Conference in Orlando to discuss Remote Therapeutic Monitoring (RTM). The post emphasizes the challenges of managing cancer patients between clinic visits, when symptoms may emerge or change and clinical teams have limited visibility.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company’s focus on RTM suggests an effort to position its offerings as tools that can add structure, visibility, and continuity to outpatient cancer care workflows. For investors, this may indicate a strategic push into technology-enabled, value-based oncology support services, potentially expanding Resilience Care’s addressable market among community oncology practices and reinforcing its role in the digital health segment of cancer care.